Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer.

about

Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer.

Item

http://www.wikidata.org/entity/Q50422213

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Cytotoxic T lymphocyte respons ...... n stage III colorectal cancer.

@en

Cytotoxic T lymphocyte respons ...... n stage III colorectal cancer.

@nl

type

Item

label

Cytotoxic T lymphocyte respons ...... n stage III colorectal cancer.

@en

Cytotoxic T lymphocyte respons ...... n stage III colorectal cancer.

@nl

prefLabel

Cytotoxic T lymphocyte respons ...... n stage III colorectal cancer.

@en

Cytotoxic T lymphocyte respons ...... n stage III colorectal cancer.

@nl

P1476

Cytotoxic T lymphocyte respons ...... in stage III colorectal cancer

@en

P2093

Fumiaki Sugiura

http://www.w3.org/2001/XMLSchema#string

Jin-Ichi Hida

http://www.w3.org/2001/XMLSchema#string

Kiyotaka Okuno

http://www.w3.org/2001/XMLSchema#string

Yasumasa Yoshioka

http://www.w3.org/2001/XMLSchema#string

Yasushi Sukegawa

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV

A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).

Capecitabine as adjuvant treatment for stage III colon cancer.

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.

Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer

UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.

P304

1545-1551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13547

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Shoichi Hazama

Junichiro Kawamura

P577

2018-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29473265

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5980387

http://www.w3.org/2001/XMLSchema#string